| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.042 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.043 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |